Proteomic Study to Survey the CIGB-552 Antitumor Effect
CIGB-552 is a cell-penetrating peptide that exerts in vitro and in vivo antitumor effect on cancer cells. In the present work, the mechanism involved in such anticancer activity was studied using chemical proteomics and expression-based proteomics in culture cancer cell lines. CIGB-552 interacts wit...
Main Authors: | Arielis Rodríguez-Ulloa, Jeovanis Gil, Yassel Ramos, Lilian Hernández-Álvarez, Lisandra Flores, Brizaida Oliva, Dayana García, Aniel Sánchez-Puente, Alexis Musacchio-Lasa, Jorge Fernández-de-Cossio, Gabriel Padrón, Luis J. González López, Vladimir Besada, Maribel Guerra-Vallespí |
---|---|
Format: | Article |
Language: | English |
Published: |
Hindawi Limited
2015-01-01
|
Series: | BioMed Research International |
Online Access: | http://dx.doi.org/10.1155/2015/124082 |
Similar Items
-
Data for comparative proteomics analysis of the antitumor effect of CIGB-552 peptide in HT-29 colon adenocarcinoma cells
by: Teresa Núñez de Villavicencio-Díaz, et al.
Published: (2015-09-01) -
The Anticancer Peptide CIGB-552 Exerts Anti-Inflammatory and Anti-Angiogenic Effects through COMMD1
by: Hellen Daghero, et al.
Published: (2021-12-01) -
Cell Penetrating Capacity and Internalization Mechanisms Used by the Synthetic Peptide CIGB-552 and Its Relationship with Tumor Cell Line Sensitivity
by: Soledad Astrada, et al.
Published: (2018-03-01) -
Targeting of Protein Kinase CK2 in Acute Myeloid Leukemia Cells Using the Clinical-Grade Synthetic-Peptide CIGB-300
by: Mauro Rosales, et al.
Published: (2021-07-01) -
CIGB-258 immunomodulatory peptide for the treatment of critical and severe COVID-19 patients
by: Rafael Venegas Rodríguez, et al.
Published: (2020-10-01)